CUROCOM Co.,Ltd. announced that it has received KRW 3 billion in funding
August 05, 2020
Share
CUROCOM.Co.Ltd. (KOSDAQ:A040350) announced a private placement of 20th non-guaranteed convertible private equity bonds for gross proceeds of KRW 3,000,000,000 on August 6, 2020. The transaction included participation from Co., W. J & Partners. The zero coupon bonds will bear a yield to maturity of 1%. The bonds will be convertible into 1,238,134 common shares of the company at a fixed conversion price of KRW 2,423 per share from August 6, 2021 to July 6, 2023. The bonds issued in the transaction will have a hold period of one year, from the closing. The bonds maturity date is August 6, 2023. The transaction has been approved by board of directors of the company.
CreoSG Co Ltd, formerly Curocom Co Ltd, is a Korea-based company mainly engaged in solution business and distribution business. The Company operates through three segments. The Solutions Business segment is engaged in the development and provision of financial consulting and software for financial institutions. Additionally, the segment is engaged in the supply of core banking solutions BANCS-K framework and BANCS-K Package to banks and other financial institutions. The Distribution Business segment is engaged in the distribution business of computers, laptops, printers, and multi-function printers. The New Drug and Vaccine Development Business segment is engaged in the development of vaccines for acquired immunodeficiency syndrome(AIDS), corona virus disease 19 (COVID-19) vaccine and other infectious diseases, and research and development of super antibiotics for Staphylococcus aureus.
CREOSG CO.,LTD. 
